Prayers were answered.

Maggie’s liver enzymes were back to normal levels, so she was able to have an infusion and restart the oral therapy. Despite the suspected progression, we’re thankful for another treatment – it is apparently keeping the lung nodules stable and may be giving additional protection/benefit.

In the exam/discussion time of our clinic visit, we had two nurse practitioners and two nurses in the room. I broached the subject of the MDA clinical trial by first making sure UAB still had no viable option for Maggie at this time. They don’t. I then told them we had been in touch with MDA and learned they had a trial opening next month. They seemed pleased and asked if we knew what type of drug(s) she would be given. When I mentioned it involves Nivolumab, the reaction was immediate and highly positive. Immunotherapy truly is the most promising treatment in use for melanoma and lung cancer and being tested now for colon cancer. Current/future Nivolumab trials involve the addition of an antibody to make it effective against colon cancer cells.

Maggie’s CT scan has been scheduled for April 12th. We’ll continue to work with MDA to schedule necessary blood tests to have Maggie qualified for the trial. This possible trial is a Phase I like the one she is involved in currently. (Phase I means all participants are guaranteed to receive active drug).

As promised, I’m sharing a link to UAB’s Comprehensive Cancer Center site for the video/article about Maggie and her participation in the Phase I trial. We are grateful for all they’ve done for Maggie and other patients and want to get the word out about their incredible program. Here’s the link: click here for Phase I trial article

Thank you for prayers – we felt their power and witnessed their answers!